The MicroRNA Quantum Code Book

Preface
Contents
Chapter 1: RNA Controls RNA
	1.1 The RNA Wave 2000
	1.2 RNA Gene Information
	1.3 Torus
	1.4 METS/MIRAI
	References
Chapter 2: MicroRNA Qubit
	2.1 Interdisciplinary Science
		2.1.1 Beyond Schrödinger’s Expectation
	References
Chapter 3: Matrix Multiplication for MicroRNA Qubit
	3.1 Hilbert Space
	3.2 Spin Rotation
	3.3 Matrix Practice
	3.4 Fluctuation and Random Numbers
	References
Chapter 4: MicroRNA Quantum Computing
	4.1 MicroRNA Memory Package (MMP)
	4.2 MicroRNA Entangling Target Sorting (METS)
	4.3 Quantum miRNA Language with Artificial Intelligence (AI) (MIRAI)
	4.4 Network Analysis
	4.5 Implementation of Electric Field Tangent Score (EFTS)
	References
Chapter 5: Vital METS/MIRAI
	5.1 Circulating MicroRNA in RNA Wave 2000
	5.2 MicroRNA/Disease Prediction in Data Science
	5.3 MicroRNA/MicroRNA Interaction
	5.4 To Quantum Calculation
	5.5 Disorder in Disorder
	References
Chapter 6: Etiology Analysis for Human Cancer
	6.1 Healthy State and Cancer
	6.2 METS Debut into Human Cancer
	6.3 Pharmacologic METS
	6.4 Stage Minus One
	6.5 The Completed Version of METS/MIRAI for Gastrointestinal Cancer
	References
Chapter 7: Encounter with the Unknown
	7.1 Human Hepatitis Virus Infection and Cancer
	7.2 COVID-19 Virus Infection
	7.3 COVID-19 Lethal Risk Factor
	7.4 Therapeutic Food miRNA Agents
	7.5 MiRNA Assessment for RNA Vaccine
	References
Chapter 8: Diabetes Mellitus: Quantum MicroRNA Language with Artificial Intelligence (MIRAI) as an Early Diagnostic Tool for Type 2 Diabetes Mellitus for Sustainable Healthcare
	8.1 Introduction
	8.2 Materials and Methods
		8.2.1 Database Usage
		8.2.2 METS/MIRAI Network Analysis
	8.3 Results and Discussion
		8.3.1 Quantum Energy Levels of T2DM
		8.3.2 METS Analysis in Pre-T2DM
		8.3.3 Pancreatic β-Cell Development in Pre-T2DM Under Obesity
		8.3.4 Pancreatic Inflammation in Pre-T2DM
		8.3.5 FOXO1 and Insulin in Pre-T2DM
		8.3.6 METS Analysis of T2DM
		8.3.7 IR in T2DM
		8.3.8 Insulin Production in T2DM
		8.3.9 Diabetic Nephropathy
		8.3.10 Validation of Network Analysis and Limitation of Dataset
	8.4 Conclusion
	References
Chapter 9: Thyroid Cancer: Quantum MicroRNA Language/Artificial Intelligence (MIRAI)-Based Etiologic Analysis of Thyroid Cancer by Serum/Plasma miRNA Panel Data
	9.1 Introduction
	9.2 Materials and Methods
		9.2.1 Data Extraction
		9.2.2 METS/MIRAI Analysis
	9.3 Results and Discussion
		9.3.1 Differentiation of PTC from Other Cancers by Quantum Energy Levels
		9.3.2 METS Analysis from Serum/Plasma miRNA Data
		9.3.3 The miRNA Surveillance to PTC
		9.3.4 METS/MIRAI Validation of PTC Etiology
	9.4 Conclusion
	References
Chapter 10: Metabolic Disease and Alzheimer’s Disease
	10.1 Age-Associated Diseases
	10.2 Alzheimer’s Disease and Mild Cognitive Impairment
	10.3 Type 2 Diabetes Mellitus
	10.4 Coronary Artery Disease
	References
Chapter 11: MiRNA Immunity Against Virus and MiRNA Surveillance Against Tumor
	11.1 Immune Surveillance
	11.2 MicroRNA Program for Surveillance Against Brain Cancer
	11.3 Discovery of Quantum MicroRNA Surveillance
	11.4 A Ghost as Immune Surveillance Against Tumor
	11.5 Discovery of Quantum MicroRNA Immunity
	11.6 A Hijacker Named Virus miRNA
	References
Chapter 12: Quantum MiRNA Code
	12.1 Importance of Panel Data
	12.2 Restriction of Data Volume
	12.3 The Biological Meaning of MMP
	12.4 MIRAI’s Future
	References
Finis
Index